Blog Posts

Will Blockchain Revolutionize Bio/Pharma R&D, Tech Transfer, and IP?


On the one hand, the Winklevoss twins asserted that Bitcoin’s price could easily go up another twenty times while Nobel-laureate economist Joseph Stieglitz admonishes that the whole concept should be illegalized all together. Either way, the blockchain open and immutable ledger transaction recording technology itself, is emerging as one of the key aspects of Bitcoin’s value proposition and when applied to other areas of business, e.g., by Ethereum, it has the potential to have an enormous impact on the mechanics of information exchange in bio/pharma R&D and as result will change how we approach legal issues of intellectual property and technology transfer.

Read the full blog post.